INVACARE CORPORATION (NYSE:IVC) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
Annual Meeting of Shareholders (the Annual Meeting), at which the
Companys shareholders acted on proposals to: (1) elect seven
directors to a one-year term that will expire at the annual meeting
of shareholders in 2018; (2) ratify the appointment of Ernst Young
LLP as the Companys independent registered public accounting firm
for the Companys 2017 fiscal year; (3) approve, on an advisory
basis, the compensation of the Companys named executive officers;
and (4) vote, on an advisory basis, regarding the frequency of
advisory votes on the compensation of the Company’s named
executive officers, and whether they will occur every one, two or
three years.
directors for a one-year term of office expiring at the annual
meeting of shareholders in 2018 with respective votes as follows:
|
Nominees
|
For
|
Withheld
|
Broker Non-Votes
|
|||
|
Susan H. Alexander
|
33,689,952
|
1,310,114
|
1,627,809
|
|||
|
Marc M. Gibeley
|
33,582,966
|
1,417,100
|
1,627,809
|
|||
|
C. Martin Harris, M.D.
|
31,430,534
|
3,569,532
|
1,627,809
|
|||
|
Michael J. Merriman
|
33,578,898
|
1,421,168
|
1,627,809
|
|||
|
Matthew E. Monaghan
|
33,583,415
|
1,416,651
|
1,627,809
|
|||
|
Clifford D. Nastas
|
33,569,211
|
1,430,855
|
1,627,809
|
|||
|
Baiju R. Shah
|
33,629,648
|
1,370,418
|
1,627,809
|
Companys independent registered public accounting firm for the
Companys 2017 fiscal year was approved with 36,284,120 votes for,
277,301 votes against and 66,454 votes abstained. There were no
broker non-votes with respect to this proposal.
the Companys named executive officers was approved with 33,478,835
votes for, 1,393,644 votes against, 127,587 votes abstained and
1,627,809 broker non-votes.
of advisory votes on the compensation of the Company’s named
executive officers, and whether they will occur every one, two or
three years resulted in approval of holding the advisory vote every
year with 29,348,718 votes for 1 year, 23,174 votes for 2 years,
5,540,661 votes for 3 years and 87,513 votes abstained.
advisory vote on the compensation of the named executive officers
would be held every year until the next vote on the frequency of
such advisory votes.
Presentation, dated May 18, 2017, on the Companys website,
http://www.invacare.com/investorrelations. The content of the
Companys website is not incorporated by reference in this Current
Report on Form 8-K.
About INVACARE CORPORATION (NYSE:IVC)
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services. INVACARE CORPORATION (NYSE:IVC) Recent Trading Information
INVACARE CORPORATION (NYSE:IVC) closed its last trading session up +0.02 at 14.65 with 462,455 shares trading hands.
